Lv3
370 积分 2024-06-26 加入
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
1个月前
已关闭
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
1个月前
已完结
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
1个月前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
1个月前
已完结
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
1个月前
已完结
Triglycerides and cardiovascular disease
2个月前
已完结
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
2个月前
已完结
Structural impact of hydrodynamic injection on mouse liver
2个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
2个月前
已完结
A novel mouse model of familial combined hyperlipidemia and atherosclerosis
2个月前
已完结
皖公网安备34019202002308
